Basis: Four-quarter free cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The free cash flow yield is N/A as of 2026-10-06T19:03:12.406Z.
Calculation as of: 2026-10-06T19:03:12.406Z.
Quote observation: 2026-10-06T19:00:10.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: bd9bff75293b0061b415f76424971e71050022ba1ca13a61eeb09eda3fdb1614
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
FREE CASH FLOW YIELD
N/A
Rapport Therapeutics, Inc. Common Stock
Market Cap
$1.48B
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.48B
Free Cash Flow Yield
0.67%
TTM Avg
1.64%
3Y Avg
3.28%
5Y Avg
2.85%
Market Cap
$1.46B
Free Cash Flow Yield
N/A
TTM Avg
14.53%
3Y Avg
14.53%
5Y Avg
14.53%
Market Cap
$1.51B
Free Cash Flow Yield
0.98%
TTM Avg
2.60%
3Y Avg
3.83%
5Y Avg
3.74%
Market Cap
$1.44B
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.44B
Free Cash Flow Yield
10.50%
TTM Avg
10.16%
3Y Avg
6.41%
5Y Avg
5.78%
Market Cap
$1.52B
Free Cash Flow Yield
18.01%
TTM Avg
21.87%
3Y Avg
15.34%
5Y Avg
11.00%
| NAME | MARKET CAP | FREE CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Rapport Therapeutics, Inc. Common Stock (RAPP) | $1.48B | N/A | N/A | N/A | N/A |
| Phibro Animal Health Corporation (PAHC)vs › | $1.48B | 0.67% | 1.64% | 3.28% | 2.85% |
| GH Research PLC (GHRS)vs › | $1.47B | N/A | N/A | N/A | N/A |
| Maze Therapeutics, Inc. (MAZE)vs › | $1.46B | N/A | 14.53% | 14.53% | 14.53% |
| Certara, Inc. (CERT)vs › | $1.46B | 4.24% | 6.20% | 4.05% | 3.26% |
| Eton Pharmaceuticals, Inc. (ETON)vs › | $1.51B | 0.98% | 2.60% | 3.83% | 3.74% |
| Ultragenyx Pharmaceutical Inc. (RARE)vs › | $1.44B | N/A | N/A | N/A | N/A |
| Healthcare Services Group, Inc. (HCSG)vs › | $1.44B | 10.50% | 10.16% | 6.41% | 5.78% |
| Nutex Health, Inc. (NUTX)vs › | $1.52B | 18.01% | 21.87% | 15.34% | 11.00% |
| Kailera Therapeutics, Inc. (KLRA)vs › | $1.43B | N/A | N/A | N/A | N/A |
FCF Yield
N/A
Earnings Yield
N/A
Dividend Yield
N/A
Formula: FCF Yield = (Free Cash Flow / Market Cap) × 100
How FCF Yield is used:
FCF vs earnings: Differences between FCF yield and earnings yield can reflect capital expenditures, working capital changes, and other non-cash accounting items.
FCF Yield measures free cash flow relative to market capitalization. It compares cash generation after capital expenditures with the equity value of the company.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
